Related Experiment Video
Updated: Aug 14, 2026
06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
Chemical probes for Alzheimer's disease targets
Sheenagh G Aiken1, Tryfon Zarganes-Tzitzikas1, Paul E Brennan1
1University of Oxford Centre for Medicines Discovery, Oxford, U.K.
Essays in Biochemistry
|August 13, 2026
Summary
Chemical probes are crucial tools for understanding Alzheimer's disease (AD) biology and validating drug targets. Rigorous selection and validation of these probes are essential for advancing AD research and developing effective treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Alzheimer's disease (AD) is a complex neurodegenerative disorder with limited disease-modifying treatments.
- Validating central nervous system (CNS) drug targets for AD remains a significant challenge.
- Chemical probes are vital for investigating specific protein functions and pathways in AD.
Purpose of the Study:
- To highlight the critical role of chemical probes in Alzheimer's disease research.
- To define the essential characteristics of high-quality chemical probes for AD target validation.
- To discuss the application and limitations of chemical probes in understanding AD pathogenesis.
Main Methods:
- Review of chemical probe utility in AD research.
- Analysis of criteria for selecting and validating CNS-penetrant chemical probes.
- Discussion of probe contributions to understanding AD-relevant pathways.
Main Results:
- Chemical probes have significantly advanced understanding of AD pathways like amyloid processing, tau aggregation, neuroinflammation, and epigenetics.
- Effective probes require high selectivity, confirmed target engagement, and appropriate CNS exposure with biomarker validation.
- Compounds initially developed as therapies have provided valuable mechanistic insights despite clinical trial outcomes.
Conclusions:
- High-quality chemical probes are indispensable tools for dissecting AD biology and validating therapeutic targets.
- Rigorous selection, validation, and experimental design are paramount for the effective use of chemical probes in AD research.
- Emerging modalities like targeted protein degradation expand the scope of chemical probe applications in AD.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...